GlassScriptPhysician profile
Omar M Ibrahim
NPI 1487853941
$139,402.40
in general payments reported to CMS, 2019-2025
18 companies · $15K in 2025
The $15K reported for 2025 was more than what 94% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $19K · 2021: $27K · 2022: $20K · 2023: $4,849 · 2024: $38K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Travel and Lodging: $14K · Food and Beverage: $4,107 · Education: $2,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,719.00 |
| Travel and Lodging | $13,535.84 |
| Food and Beverage | $4,106.94 |
| Education | $2,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $92,146.35 | 2019-2025 | Monarch Platform, N/A |
| Medical Device Business Services, INC. | $21,199.71 | 2023-2025 | Monarch |
| Ethicon Endo-Surgery INC. | $16,139.28 | 2023-2024 | Monarch Platform, Neuwave |
| Intuitive Surgical, INC. | $4,728.22 | 2021-2025 | |
| Noah Medical Corporation | $2,132.59 | 2023-2025 | Galaxy |
| Pulmonx Corporation | $1,168.76 | 2019-2023 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Galvanize Therapeutics, INC | $500.05 | 2023-2025 | Aliya System |
| Pinnacle Biologics, INC | $360.02 | 2022 | |
| Covidien LP | $235.88 | 2019-2020 | |
| Boston Scientific Corporation | $208.21 | 2019-2022 | |
| Merz North America, INC. | $151.21 | 2019 | |
| Medtronic, INC. | $143.08 | 2021 | |
| Janssen Research & Development, LLC | $112.70 | 2021 | |
| Lexington Medical, INC. | $94.51 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Allergan, INC. | $31.35 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $25.93 | 2025 | |
| Kite Pharma, INC. | $24.55 | 2025 | Yescarta |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.